Search research articles
Contact Us
Filters
Showing results (341-350 of 348) with videos related to
Page
of 35
Sort By:
You have reached the last page of results.
This site can display upto 348 results.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2015
Novel phenylalanine derived diamides as Factor XIa inhibitors
Leon M Smith, Michael J Orwat, Zilun Hu, et al.
ACS Medicinal Chemistry Letters
|
January 8, 2019
Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)
Jun Li, Lawrence J Kennedy, Steven J Walker, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 11, 2011
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)
Shung C Wu, David Yoon, Janice Chin, et al.
Archives of Biochemistry and Biophysics
|
February 8, 2003
Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzyme
Lisa M Kopcho, Jianhong Ma, Jovita Marcinkeviciene, et al.
The New Phytologist
|
November 19, 2011
The transcriptome of the arbuscular mycorrhizal fungus Glomus intraradices (DAOM 197198) reveals functional tradeoffs in an obligate symbiont
E Tisserant, A Kohler, P Dozolme-Seddas, et al.
Journal of Medicinal Chemistry
|
May 25, 2017
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor
Xiang-Yang Ye, Stephanie Y Chen, Shung Wu, et al.
Journal of Medicinal Chemistry
|
January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase
Robert G Gentles, Min Ding, John A Bender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
H Bourgeois, F Grudé, P Solal-Céligny, et al.
Page
of 35
Search research articles
Search
Showing results (341-350 of 348) with videos related to
Sort By:
Page
of 35
You have reached the last page of results.
This site can display upto 348 results.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2015
Novel phenylalanine derived diamides as Factor XIa inhibitors
Leon M Smith, Michael J Orwat, Zilun Hu, et al.
ACS Medicinal Chemistry Letters
|
January 8, 2019
Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)
Jun Li, Lawrence J Kennedy, Steven J Walker, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 11, 2011
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)
Shung C Wu, David Yoon, Janice Chin, et al.
Archives of Biochemistry and Biophysics
|
February 8, 2003
Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzyme
Lisa M Kopcho, Jianhong Ma, Jovita Marcinkeviciene, et al.
The New Phytologist
|
November 19, 2011
The transcriptome of the arbuscular mycorrhizal fungus Glomus intraradices (DAOM 197198) reveals functional tradeoffs in an obligate symbiont
E Tisserant, A Kohler, P Dozolme-Seddas, et al.
Journal of Medicinal Chemistry
|
May 25, 2017
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor
Xiang-Yang Ye, Stephanie Y Chen, Shung Wu, et al.
Journal of Medicinal Chemistry
|
January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase
Robert G Gentles, Min Ding, John A Bender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
H Bourgeois, F Grudé, P Solal-Céligny, et al.
Page
of 35